Vision Loss News and Research

RSS

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.

31 Jul 2018

OHSU researchers discover disease in monkeys that mimics childhood neurodegenerative disorder

OHSU scientists have discovered a naturally occurring disease in monkeys that mimics a deadly childhood neurodegenerative disorder in people - a finding that holds promise for developing new gene therapies to treat Batten disease.

27 Jul 2018

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

The advent of electronic medical records with large image databases, along with advances in artificial intelligence with deep learning, is offering medical professionals new opportunities to dramatically improve image analysis and disease diagnostics.

29 Jun 2018

New therapeutic approach may delay neurodegeneration in rare genetic disease

A new therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB. Neurodegeneration in this condition results from the abnormal accumulation of essential cellular molecules called mucopolysaccharides.

21 Jun 2018

Persistent psychological stress contributes to development and progression of vision loss

Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study now published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and Personalized Medicine.

19 Jun 2018

Microglia play protective role in response to retinal detachment, shows study

A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.

19 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Study reveals 133 genetic variants that may improve risk prediction for glaucoma

Researchers funded by the National Eye Institute have identified 133 genetic variants that predict with 75-percent accuracy a person's risk for developing glaucoma related to elevated pressure within the eye.

31 May 2018

New study shows that epigenetic silencing of genes limits eye development of cave fish

Loss of eye tissue in blind cavefish (Astyanax mexicanus), which occurs within a few days of their development, happens through epigenetic silencing of eye-related genes, according to a study led by the National Institutes of Health. Epigenetic regulation is a process where genes are turned off or on, typically in a reversible or temporary manner.

29 May 2018

Columbia researchers develop new non-invasive approach to permanently correct vision

Nearsightedness, or myopia, is an increasing problem around the world. There are now twice as many people in the US and Europe with this condition as there were 50 years ago. In East Asia, 70 to 90 percent of teenagers and young adults are nearsighted.

29 May 2018

New non-invasive approach could permanently correct vision

Nearsightedness, or myopia, is an increasing problem around the world. There are now twice as many people in the US and Europe with this condition as there were 50 years ago.

29 May 2018

Researchers seek new approaches to better protect the eye from glaucoma

Under the increased pressure of glaucoma, scientists want to help the neurons in our eyes better protect themselves and get better help from their friends.

29 May 2018

Study shows lack of follow-up care for patients with concussion

Millions of Americans suffer concussions each year, and many endure symptoms for months or years afterward. A new study shows that a majority of patients with a concussion receive no follow-up care within three months of discharge from the hospital.

25 May 2018

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

22 May 2018

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit.

From Siemens Healthineers Point of Care Diagnostics 16 May 2018

Study uncovers new circuit that fine tunes brain's decision to hide or confront threats

In a study of mice, National Institutes of Health-funded researchers describe a new circuit involved in fine-tuning the brain's decision either to hide or confront threats.

11 May 2018

Nearly 50 people present with rare eye cancer - ocular melanoma

At least 50 people have been diagnosed with a rare type of eye cancer called ocular melanoma. They are all residents of two locations - Huntersville, North Carolina, and Auburn, Alabama. The cancer is rare and occurs in only six per 1 million population. The high rate of incidence of this cancer in these two locations has stumped researchers.

2 May 2018

Vision Loss News and Research

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

OHSU researchers discover disease in monkeys that mimics childhood neurodegenerative disorder

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

New therapeutic approach may delay neurodegeneration in rare genetic disease

Persistent psychological stress contributes to development and progression of vision loss

Microglia play protective role in response to retinal detachment, shows study

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Study reveals 133 genetic variants that may improve risk prediction for glaucoma

New study shows that epigenetic silencing of genes limits eye development of cave fish

Columbia researchers develop new non-invasive approach to permanently correct vision

New non-invasive approach could permanently correct vision

Researchers seek new approaches to better protect the eye from glaucoma

Study shows lack of follow-up care for patients with concussion

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Study uncovers new circuit that fine tunes brain's decision to hide or confront threats

Nearly 50 people present with rare eye cancer - ocular melanoma

Researchers develop new methods to diagnose glaucoma and detect disease progression

Ways to manage diabetes apart from intensifying glucose control

FDA authorizes marketing of first AI device to detect diabetic retinopathy

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News